Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation–Positive Melanoma: Patient Selection and Perspectives
-
Published:2024-07
Issue:
Volume:Volume 16
Page:933-939
-
ISSN:1179-1322
-
Container-title:Cancer Management and Research
-
language:en
-
Short-container-title:CMAR
Author:
Dugan MichelleORCID,
Perez Matthew,
Karapetyan Lilit,
Zager JonathanORCID
Publisher
Informa UK Limited